Evidence map›Paper›PMID 23169579›Full record

ArticleStem cells (Dayton, Ohio)2013

Transcription elongation factor Tcea3 regulates the pluripotent differentiation potential of mouse embryonic stem cells via the Lefty1-Nodal-Smad2 pathway.

Kyung-Soon Park, Young Cha, Chun-Hyung Kim, Hee-Jin Ahn, Dohoon Kim, Sanghyeok Ko, Kyeoung-Hwa Kim, Mi-Yoon Chang, Jong-Hyun Ko, Yoo-Sun Noh and 8 more

Abstract read
In one paragraph

Article in Stem cells (Dayton, Ohio), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Single cell transcriptome dynamics from pluripotency to FLK1Development (Cambridge, England) · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. TCEA3 Attenuates Gastric Cancer Growth by Apoptosis Induction.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 3 countries.

Kyung-Soon ParkDepartment of Biomedical Science, College of Life Science, CHA University, Seoul, Korea. kspark@cha.ac.kr
Young Cha
Chun-Hyung Kim
Hee-Jin Ahn
Dohoon Kim
Sanghyeok Ko
Kyeoung-Hwa Kim
Mi-Yoon Chang
Jong-Hyun Ko
Yoo-Sun Noh
Yong-Mahn Han
Jonghwan Kim
Jihwan Song
Jin Young Kim
Paul J Tesar
Robert Lanza
Kyung-Ah Lee
Kwang-Soo Kim
CHA University · KRHarvard University · USSeoul National University · KRThe University of Texas at Austin · USAdvanced Cell Technology (United States) · USCase Western Reserve University · USHarvard Stem Cell Institute · USLife University · USMcLean Hospital · US

Funding

Protein-induced human iPS cells for personalized cell therapy of PDR01NS070577 · NINDS · MCLEAN HOSPITAL · PI KIM, KWANG-SOO, KORDOWER, JEFFREY H · 2010 to 2020
$4.9M
Patient-specific and universal donor blood cell from protein-induced iPS cellsRC4HL106627 · NHLBI · MCLEAN HOSPITAL · PI KIM, KWANG-SOO, LANZA, ROBERT P · 2010 to 2010
$1.9M
Functional Roles of Nurr1 for Midbrain Dopamine Neurons in Health and DiseaseR01NS084869 · NINDS · MCLEAN HOSPITAL · PI KIM, KWANG-SOO · 2014 to 2018
$1.7M
Optimal Generation and Characterization of iPS Cell Lines from Healthy and ADHD SR33MH087903 · NIMH · MCLEAN HOSPITAL · PI KIM, KWANG-SOO · 2011 to 2012
$784k
Optimal Generation and Characterization of iPS Cell Lines from Healthy and ADHD SR21MH087903 · NIMH · MCLEAN HOSPITAL · PI KIM, KWANG-SOO · 2009 to 2010
$627k
NHLBI NIH HHS HL106627NHLBI NIH HHS RC4 HL106627NIMH NIH HHS MH087903NIMH NIH HHS R21 MH087903NIMH NIH HHS R33 MH087903NINDS NIH HHS NS070577NINDS NIH HHS R01 NS070577NINDS NIH HHS R01 NS084869
6 · The paper itself

Abstract

Self-renewal and pluripotency are hallmark properties of pluripotent stem cells, including embryonic stem cells (ESCs) and iPS cells. Previous studies revealed the ESC-specific core transcription circuitry and showed that these core factors (e.g., Oct3/4, Sox2, and Nanog) regulate not only self-renewal but also pluripotent differentiation. However, it remains elusive how these two cell states are regulated and balanced during in vitro replication and differentiation. Here, we report that the transcription elongation factor Tcea3 is highly enriched in mouse ESCs (mESCs) and plays important roles in regulating the differentiation. Strikingly, altering Tcea3 expression in mESCs did not affect self-renewal under nondifferentiating condition; however, upon exposure to differentiating cues, its overexpression impaired in vitro differentiation capacity, and its knockdown biased differentiation toward mesodermal and endodermal fates. Furthermore, we identified Lefty1 as a downstream target of Tcea3 and showed that the Tcea3-Lefty1-Nodal-Smad2 pathway is an innate program critically regulating cell fate choices between self-replication and differentiation commitment. Together, we propose that Tcea3 critically regulates pluripotent differentiation of mESCs as a molecular rheostat of Nodal-Smad2/3 signaling.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsCell DifferentiationCell ProliferationEmbryonic Stem CellsEndodermGene Expression ProfilingLeft-Right Determination FactorsMesodermMiceNodal ProteinPluripotent Stem CellsSignal TransductionSmad2 ProteinTranscriptional Elongation FactorsLeft-Right Determination FactorsLefty1 protein, mouseNodal ProteinNodal protein, mouseSmad2 ProteinSmad2 protein, mouseTranscriptional Elongation Factorstranscription factor S-II

Identifiers

PMID23169579
PMCPMC3572291
OpenAlexW1979556178

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.